A citation-based method for searching scientific literature

Skylar Luu, Haley Province, Elizabeth Berry-Kravis, Randi Hagerman, David Hessl, Dhananjay Vaidya, Reymundo Lozano, Hilary Rosselot, Craig Erickson, Walter E Kaufmann, Dejan B Budimirovic. Brain Sci 2020
Times Cited: 3







List of co-cited articles
10 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Autism spectrum disorder in Fragile X syndrome: differential contribution of adaptive socialization and social withdrawal.
Dejan B Budimirovic, Irena Bukelis, Christiane Cox, Robert M Gray, Elaine Tierney, Walter E Kaufmann. Am J Med Genet A 2006
64
66

A Genotype-Phenotype Study of High-Resolution FMR1 Nucleic Acid and Protein Analyses in Fragile X Patients with Neurobehavioral Assessments.
Dejan B Budimirovic, Annette Schlageter, Stela Filipovic-Sadic, Dragana D Protic, Eran Bram, E Mark Mahone, Kimberly Nicholson, Kristen Culp, Kamyab Javanmardi, Jon Kemppainen,[...]. Brain Sci 2020
20
66

Arbaclofen in fragile X syndrome: results of phase 3 trials.
Elizabeth Berry-Kravis, Randi Hagerman, Jeannie Visootsak, Dejan Budimirovic, Walter E Kaufmann, Maryann Cherubini, Peter Zarevics, Karen Walton-Bowen, Paul Wang, Mark F Bear,[...]. J Neurodev Disord 2017
78
66

Mavoglurant in fragile X syndrome: Results of two randomized, double-blind, placebo-controlled trials.
Elizabeth Berry-Kravis, Vincent Des Portes, Randi Hagerman, Sébastien Jacquemont, Perrine Charles, Jeannie Visootsak, Marc Brinkman, Karin Rerat, Barbara Koumaras, Liansheng Zhu,[...]. Sci Transl Med 2016
145
66

Autism Spectrum Disorder in Fragile X Syndrome: Cooccurring Conditions and Current Treatment.
Walter E Kaufmann, Sharon A Kidd, Howard F Andrews, Dejan B Budimirovic, Amy Esler, Barbara Haas-Givler, Tracy Stackhouse, Catharine Riley, Georgina Peacock, Stephanie L Sherman,[...]. Pediatrics 2017
77
66

Autism Symptoms in Fragile X Syndrome.
Manman Niu, Ying Han, Angel Belle C Dy, Junbao Du, Hongfang Jin, Jiong Qin, Jing Zhang, Qinrui Li, Randi J Hagerman. J Child Neurol 2017
28
66

Updated report on tools to measure outcomes of clinical trials in fragile X syndrome.
Dejan B Budimirovic, Elizabeth Berry-Kravis, Craig A Erickson, Scott S Hall, David Hessl, Allan L Reiss, Margaret K King, Leonard Abbeduto, Walter E Kaufmann. J Neurodev Disord 2017
62
66

A multicenter study on genotype-phenotype correlations in the fragile X syndrome, using direct diagnosis with probe StB12.3: the first 2,253 cases.
F Rousseau, D Heitz, J Tarleton, J MacPherson, H Malmgren, N Dahl, A Barnicoat, C Mathew, E Mornet, I Tejada. Am J Hum Genet 1994
243
66

Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome.
Elizabeth M Berry-Kravis, Lothar Lindemann, Aia E Jønch, George Apostol, Mark F Bear, Randall L Carpenter, Jacqueline N Crawley, Aurore Curie, Vincent Des Portes, Farah Hossain,[...]. Nat Rev Drug Discov 2018
135
66

Mosaicism in fragile X affected males.
S L Nolin, A Glicksman, G E Houck, W T Brown, C S Dobkin. Am J Med Genet 1994
125
66

The future of sleep health: a data-driven revolution in sleep science and medicine.
Ignacio Perez-Pozuelo, Bing Zhai, Joao Palotti, Raghvendra Mall, Michaël Aupetit, Juan M Garcia-Gomez, Shahrad Taheri, Yu Guan, Luis Fernandez-Luque. NPJ Digit Med 2020
22
33


The future of sleep health: a data-driven revolution in sleep science and medicine.
Ignacio Perez-Pozuelo, Bing Zhai, Joao Palotti, Raghvendra Mall, Michaël Aupetit, Juan M Garcia-Gomez, Shahrad Taheri, Yu Guan, Luis Fernandez-Luque. NPJ Digit Med 2020
20
33

Discovering translational biomarkers in neurodevelopmental disorders.
Mustafa Sahin, Stephanie R Jones, John A Sweeney, Elizabeth Berry-Kravis, Barry W Connors, Joshua B Ewen, Adam L Hartman, April R Levin, William Z Potter, Laura A Mamounas. Nat Rev Drug Discov 2018
22
33

The neurobiology of the Prader-Willi phenotype of fragile X syndrome.
Zukhrofi Muzar, Reymundo Lozano, Alexander Kolevzon, Randi J Hagerman. Intractable Rare Dis Res 2016
9
33

Effects of STX209 (arbaclofen) on neurobehavioral function in children and adults with fragile X syndrome: a randomized, controlled, phase 2 trial.
Elizabeth M Berry-Kravis, David Hessl, Barbara Rathmell, Peter Zarevics, Maryann Cherubini, Karen Walton-Bowen, Yi Mu, Danh V Nguyen, Joseph Gonzalez-Heydrich, Paul P Wang,[...]. Sci Transl Med 2012
217
33

A fragile X mosaic male with a cryptic full mutation detected in epithelium but not in blood.
A Maddalena, K N Yadvish, W C Spence, P N Howard-Peebles. Am J Med Genet 1996
25
33

A pilot open label, single dose trial of fenobam in adults with fragile X syndrome.
E Berry-Kravis, D Hessl, S Coffey, C Hervey, A Schneider, J Yuhas, J Hutchison, M Snape, M Tranfaglia, D V Nguyen,[...]. J Med Genet 2009
264
33

Analysis of FMR1 gene expression in female premutation carriers using robust segmented linear regression models.
Eva García-Alegría, Berta Ibáñez, Mónica Mínguez, Marisa Poch, Alberto Valiente, Arantza Sanz-Parra, Cristina Martinez-Bouzas, Elena Beristain, Maria-Isabel Tejada. RNA 2007
37
33

Instability of the CGG repeat and expression of the FMR1 protein in a male fragile X patient with a lung tumor.
E de Graaff, R Willemsen, N Zhong, C E de Die-Smulders, W T Brown, G Freling, B Oostra. Am J Hum Genet 1995
48
33

Inhibition of phosphodiesterase-4D in adults with fragile X syndrome: a randomized, placebo-controlled, phase 2 clinical trial.
Elizabeth M Berry-Kravis, Mark D Harnett, Scott A Reines, Melody A Reese, Lauren E Ethridge, Abigail H Outterson, Claire Michalak, Jeremiah Furman, Mark E Gurney. Nat Med 2021
7
33

Neurodevelopmental Disorders: From Genetics to Functional Pathways.
Ilaria Parenti, Luis G Rabaneda, Hanna Schoen, Gaia Novarino. Trends Neurosci 2020
41
33

Fragile X checklists: A meta-analysis and development of a simplified universal clinical checklist.
Toni Kasole Lubala, Aimé Lumaka, Gray Kanteng, Léon Mutesa, Olivier Mukuku, Stanislas Wembonyama, Randi Hagerman, Oscar Numbi Luboya, Prosper Lukusa Tshilobo. Mol Genet Genomic Med 2018
8
33

Characterization of potential outcome measures for future clinical trials in fragile X syndrome.
Elizabeth Berry-Kravis, Allison Sumis, Ok-Kyung Kim, Rebecca Lara, Joanne Wuu. J Autism Dev Disord 2008
19
33

Lithium ameliorates altered glycogen synthase kinase-3 and behavior in a mouse model of fragile X syndrome.
Christopher J Yuskaitis, Marjelo A Mines, Margaret K King, J David Sweatt, Courtney A Miller, Richard S Jope. Biochem Pharmacol 2010
128
33

Psychological well-being of mothers of youth with fragile X syndrome: syndrome specificity and within-syndrome variability.
P Lewis, L Abbeduto, M Murphy, E Richmond, N Giles, L Bruno, S Schroeder, J Anderson, G Orsmond. J Intellect Disabil Res 2006
47
33

FMR1 mRNA from full mutation alleles is associated with ABC-CFX scores in males with fragile X syndrome.
Emma K Baker, Marta Arpone, Claudine Kraan, Minh Bui, Carolyn Rogers, Michael Field, Lesley Bretherton, Ling Ling, Alexandra Ure, Jonathan Cohen,[...]. Sci Rep 2020
4
33

Phenotypic variation and FMRP levels in fragile X.
Danuta Z Loesch, Richard M Huggins, Randi J Hagerman. Ment Retard Dev Disabil Res Rev 2004
191
33

Therapeutic Strategies in Fragile X Syndrome: From Bench to Bedside and Back.
Christina Gross, Anne Hoffmann, Gary J Bassell, Elizabeth M Berry-Kravis. Neurotherapeutics 2015
58
33

A marker X chromosome.
H A Lubs. Am J Hum Genet 1969
514
33

Self-injurious behavior and fragile X syndrome: findings from the national fragile X survey.
Frank J Symons, Breanne J Byiers, Melissa Raspa, Ellen Bishop, Donald B Bailey. Am J Intellect Dev Disabil 2010
52
33

Tissue differences in fragile X mosaics: mosaicism in blood cells may differ greatly from skin.
C S Dobkin, S L Nolin, I Cohen, V Sudhalter, M G Bialer, X H Ding, E C Jenkins, N Zhong, W T Brown. Am J Med Genet 1996
39
33

Perspectives on pain and intellectual disability.
F J Symons, S K Shinde, E Gilles. J Intellect Disabil Res 2008
28
33

High functioning fragile X males: demonstration of an unmethylated fully expanded FMR-1 mutation associated with protein expression.
R J Hagerman, C E Hull, J F Safanda, I Carpenter, L W Staley, R A O'Connor, C Seydel, M M Mazzocco, K Snow, S N Thibodeau. Am J Med Genet 1994
172
33

High functioning male with fragile X syndrome and fragile X-associated tremor/ataxia syndrome.
Kirin Basuta, Andrea Schneider, Louise Gane, Jonathan Polussa, Bryan Woodruff, Dalyir Pretto, Randi Hagerman, Flora Tassone. Am J Med Genet A 2015
18
33

High-functioning autism spectrum disorder and fragile X syndrome: report of two affected sisters.
Pauline Chaste, Catalina Betancur, Marion Gérard-Blanluet, Anne Bargiacchi, Suzanne Kuzbari, Séverine Drunat, Marion Leboyer, Thomas Bourgeron, Richard Delorme. Mol Autism 2012
9
33

Fragile X syndrome.
Kathryn B Garber, Jeannie Visootsak, Stephen T Warren. Eur J Hum Genet 2008
234
33

Clinical and molecular implications of mosaicism in FMR1 full mutations.
Dalyir Pretto, Carolyn M Yrigollen, Hiu-Tung Tang, John Williamson, Glenda Espinal, Chris K Iwahashi, Blythe Durbin-Johnson, Randi J Hagerman, Paul J Hagerman, Flora Tassone. Front Genet 2014
60
33


Emerging pharmacologic treatment options for fragile X syndrome.
Tori L Schaefer, Matthew H Davenport, Craig A Erickson. Appl Clin Genet 2015
25
33

Mutation-specific pathophysiological mechanisms define different neurodevelopmental disorders associated with SATB1 dysfunction.
Joery den Hoed, Elke de Boer, Norine Voisin, Alexander J M Dingemans, Nicolas Guex, Laurens Wiel, Christoffer Nellaker, Shivarajan M Amudhavalli, Siddharth Banka, Frederique S Bena,[...]. Am J Hum Genet 2021
6
33

Size and methylation mosaicism in males with Fragile X syndrome.
Poonnada Jiraanont, Madhur Kumar, Hiu-Tung Tang, Glenda Espinal, Paul J Hagerman, Randi J Hagerman, Nuanchan Chutabhakdikul, Flora Tassone. Expert Rev Mol Diagn 2017
20
33

Neurodevelopmental disorders: prevalence and comorbidity in children referred to mental health services.
Berit Hjelde Hansen, Beate Oerbeck, Benedicte Skirbekk, Beáta Éva Petrovski, Hanne Kristensen. Nord J Psychiatry 2018
29
33

Seizures in fragile X syndrome: characteristics and comorbid diagnoses.
Elizabeth Berry-Kravis, Melissa Raspa, Lisa Loggin-Hester, Ellen Bishop, David Holiday, Donald B Bailey. Am J Intellect Dev Disabil 2010
85
33

Molecular mechanisms of fragile X syndrome: a twenty-year perspective.
Michael R Santoro, Steven M Bray, Stephen T Warren. Annu Rev Pathol 2012
340
33

Fragile X syndrome: a review of clinical and molecular diagnoses.
Claudia Ciaccio, Laura Fontana, Donatella Milani, Silvia Tabano, Monica Miozzo, Susanna Esposito. Ital J Pediatr 2017
52
33


Clinical and molecular studies in fragile X patients with a Prader-Willi-like phenotype.
B B de Vries, J P Fryns, M G Butler, F Canziani, E Wesby-van Swaay, J O van Hemel, B A Oostra, D J Halley, M F Niermeijer. J Med Genet 1993
69
33

The challenges of clinical trials in fragile X syndrome.
Sébastien Jacquemont, Elizabeth Berry-Kravis, Randi Hagerman, Florian von Raison, Fabrizio Gasparini, George Apostol, Mike Ufer, Vincent Des Portes, Baltazar Gomez-Mancilla. Psychopharmacology (Berl) 2014
70
33

FORWARD: A Registry and Longitudinal Clinical Database to Study Fragile X Syndrome.
Stephanie L Sherman, Sharon A Kidd, Catharine Riley, Elizabeth Berry-Kravis, Howard F Andrews, Robert M Miller, Sharyn Lincoln, Mark Swanson, Walter E Kaufmann, W Ted Brown. Pediatrics 2017
20
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.